How big is the Insulin Delivery Devices Market?

The Insulin Delivery Devices Market size is expected to reach USD 39.57 billion in 2024 and grow at a CAGR of 3.57% to reach USD 47.17 billion by 2029. Read More

What is the current Insulin Delivery Devices Market size?

In 2024, the Insulin Delivery Devices Market size is expected to reach USD 39.57 billion. Read More

Who are the key players in Insulin Delivery Devices Market?

Novo Nordisk, Medtronic, Sanofi, Ypsomed and Eli Lilly and Company are the major companies operating in the Insulin Delivery Devices Market. Read More

Which is the fastest growing region in Insulin Delivery Devices Market?

North America is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Insulin Delivery Devices Market?

In 2024, the Asia Pacific accounts for the largest market share in Insulin Delivery Devices Market. Read More

What years does this Insulin Delivery Devices Market cover, and what was the market size in 2023?

In 2023, the Insulin Delivery Devices Market size was estimated at USD 38.21 billion. The report covers the Insulin Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Insulin Delivery Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Insulin Delivery Devices Market - Growth, Size & Trends

Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Insulin Delivery Devices Market Share and it is segmented by Type (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, Jet Injectors), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). The market values are provided in terms of (USD million) for the above segments.

Insulin Delivery Devices Industry Overview

The insulin delivery devices market is consolidated due to only a few major companies operating globally and regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known, including Novo Nordisk, Sanofi, Eli Lily and Company, Medtronic, Insulet, Ypsomped, Becton, Dickinson and Company, among others.